Pictet Asset Management (Switzerland)’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $119M | Sell |
9,442,588
-542,313
| -5% | -$6.81M | 0.14% | 180 |
|
|
2023
Q1 | $111M | Buy |
9,984,901
+1,553,949
| +18% | +$17.2M | 0.14% | 188 |
|
|
2022
Q4 | $103M | Buy |
8,430,952
+4,945,650
| +142% | +$60.4M | 0.15% | 188 |
|
|
2022
Q3 | $36.4M | Buy |
3,485,302
+2,842,220
| +442% | +$29.7M | 0.05% | 324 |
|
|
2022
Q2 | $6.91M | Buy |
643,082
+229,613
| +56% | +$2.47M | 0.01% | 680 |
|
|
2022
Q1 | $3.92M | Sell |
413,469
-8,348
| -2% | -$79.1K | ﹤0.01% | 854 |
|
|
2021
Q4 | $4.87M | Buy |
421,817
+28,773
| +7% | +$332K | ﹤0.01% | 833 |
|
|
2021
Q3 | $3.75M | Buy |
+393,044
| New | +$3.75M | ﹤0.01% | 893 |
|